How is the Inhibrx Inc today?

The Inhibrx Inc today is trading in the green, up by 4.81% at 13.07.

What is Inhibrx Inc Annual Revenue?

Inhibrx Inc Annual Revenue fell 17.36%, in the last year to $1.8 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Inhibrx Inc Annual Net Profit?

Inhibrx Inc Annual Net Profit fell 66.2% in the last year to $241.36 M. Its sector's average net profit growth for the last fiscal year was -11.16%.

What is Inhibrx Inc Price to Earning Ratio?

Inhibrx Inc Price to Earning Ratio is -2.28, which is negative.

What is Inhibrx Inc Stock Price?

Inhibrx Inc Stock Price fell 62.33% and underperformed its sector by 76.21% in the past year.

What is Inhibrx Inc Quarterly Net profit?

Inhibrx Inc Quarterly Net profit fell 60.91% YoY to $78.71 M. Its sector's average net profit growth YoY for the quarter was -200.49%.

What is Inhibrx Inc Debt to Equity Ratio?

Inhibrx Inc Debt to Equity Ratio of 4.83 is higher than 1. This implies that company assets are financed through debt.

What is Inhibrx Inc Return on Equity(ROE)?

Inhibrx Inc Return on Equity(ROE) for the last financial year was -475.31%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Inhibrx Inc Mutual Fund Holding?

Inhibrx Inc Mutual Fund Holding decreased by 2.19% in the last quarter to 22.01.

What is Inhibrx Inc Interest Coverage Ratio?

Inhibrx Inc Interest Coverage Ratio is -6.53, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Inhibrx Inc Institutional Holding?

Inhibrx Inc Institutional Holding decreased by 8.08% in the last quarter to 70.52.

Inhibrx Inc XNAS: INBX

Inhibrx Inc Live Share Price Today, Share Analysis and Chart

Name: Inhibrx Inc: Is Infosys Ltd. worth buying?
Item: Inhibrx Inc
Rating: 0.98216675
Author: Trendlyne DVM scores

about

Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...

13.07 0.60 (4.81%)

62.35% Fall from 52W High

194.3K XNAS Volume

High volume today

XNAS 20 May, 2025 4:01 PM (EDT)

Not Eligible

-

Expensive Valuation

1.7 / 100

Technically Neutral

37.6 / 100

12

1Yr Price target downside is -8%

1 analysts

Inhibrx Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Inhibrx Inc FAQ

How is Inhibrx Inc today?

Inhibrx Inc today is trading in the green, and is up by 4.81% at 13.07.

How has Inhibrx Inc performed historically?

Inhibrx Inc is currently trading up 4.81% on an intraday basis. In the past week the stock rose 11.61%. stock has been up 1.71% in the past quarter and fell -62.33% in the past year. You can view this in the overview section.